| [1] |
Wong WL, Su X, Li X, Cheung CMG, Klein R, et al. 2014. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. |
| [2] |
Tham YC, Li X, Wong TY, Quigley HA, Aung T, et al. 2014. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. |
| [3] |
Solano AGR, de Fátima Pereira A, de Faria LGA, Fialho SL, de Oliveira Patricio PS, et al. 2018. Etoposide-loaded poly(lactic-co-glycolic acid) intravitreal implants: in vitro and in vivo evaluation. |
| [4] |
McAvoy K, Jones D, Thakur RRS. 2018. Synthesis and characterisation of photocrosslinked poly(ethylene glycol) diacrylate implants for sustained ocular drug delivery. |
| [5] |
Zhao X, Lang Q, Yildirimer L, Lin ZY, Cui W, et al. 2016. Photocrosslinkable gelatin hydrogel for epidermal tissue engineering. |
| [6] |
Komez A, Baran ET, Erdem U, Hasirci N, Hasirci V. 2016. Construction of a patterned hydrogel—fibrous mat bilayer structure to mimic choroid and Bruch's membrane layers of retina. |
| [7] |
Zhao X, Li S, Du X, Li W, Wang Q, et al. 2022. Natural polymer-derived photocurable bioadhesive hydrogels for sutureless keratoplasty. |
| [8] |
Luo Z, Sun W, Fang J, Lee K, Li S, et al. 2019. Biodegradable gelatin methacryloyl microneedles for transdermal drug delivery. |
| [9] |
Mamidi N, Ijadi F, Norahan MH. 2024. Leveraging the recent advancements in GelMA scaffolds for bone tissue engineering: an assessment of challenges and opportunities. |
| [10] |
Liu Y, Chan-Park MB. 2010. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture. |
| [11] |
Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, et al. 2015. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. |
| [12] |
Noshadi I, Hong S, Sullivan KE, Shirzaei Sani E, Portillo-Lara R, et al. 2017. In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels. |
| [13] |
Kresloff MS, Castellarin AA, Zarbin MA. 1998. Endophthalmitis. |
| [14] |
Mamidi N, Delgadillo RMV, Sustaita AO, Lozano K, Yallapu MM. 2025. Current nanocomposite advances for biomedical and environmental application diversity. |
| [15] |
Yang C, Gao L, Liu X, Yang T, Yin G, et al. 2019. Injectable Schiff base polysaccharide hydrogels for intraocular drug loading and release. |
| [16] |
Pawar P, Kashyap H, Malhotra S, Sindhu R. 2013. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment. |
| [17] |
Cuming RS, Abarca EM, Duran S, Wooldridge AA, Stewart AJ, et al. 2017. Development of a sustained-release voriconazole-containing thermogel for subconjunctival injection in horses. |
| [18] |
Shen C, Zhao X, Ren Z, Yang B, Wang X, et al. 2023. In situ formation of injectable gelatin methacryloyl (GelMA) hydrogels for effective intraocular delivery of triamcinolone acetonide. |
| [19] |
Zhang P, Wang H, Wang P, Zheng Y, Liu L, et al. 2021. Lightweight 3D bioprinting with point by point photocuring. |
| [20] |
Zhang H, Yu R, Xia Y, Liu J, Tu R, et al. 2024. Effect of magnesium and calcium ions on the strength and biofunctionality of GelMA/SAMA composite hydrogels. |
| [21] |
Chen YC, Lin RZ, Qi H, Yang Y, Bae H, et al. 2012. Functional human vascular network generated in photocrosslinkable gelatin methacrylate hydrogels. |
| [22] |
ARVO. 2024. ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Rockville, MD: Association for Research in Vision and Ophthalmology. pp. 1−6 www.arvo.org/uploads/files/general/2024-arvo-statement-for-the-use-of-animals-in-ophthalmic-and-vision-research.pdf |
| [23] |
Worthington KS, Wiley LA, Bartlett AM, Stone EM, Mullins RF, et al. 2014. Mechanical properties of murine and porcine ocular tissues in compression. |
| [24] |
Arya AD, Hallur PM, Karkisaval AG, Gudipati A, Rajendiran S, et al. 2016. Gelatin methacrylate hydrogels as biomimetic three-dimensional matrixes for modeling breast cancer invasion and chemoresponse in vitro. |
| [25] |
Miri AK, Hosseinabadi HG, Cecen B, Hassan S, Zhang YS. 2018. Permeability mapping of gelatin methacryloyl hydrogels. |
| [26] |
Mamidi N, De Silva FF, Vacas AB, Gutiérrez Gómez JA, Montes Goo NY, et al. 2024. Multifaceted hydrogel scaffolds: bridging the gap between biomedical needs and environmental sustainability. |
| [27] |
Chen L, Li L, Mo Q, Zhang X, Chen C, et al. 2023. An injectable gelatin/sericin hydrogel loaded with human umbilical cord mesenchymal stem cells for the treatment of uterine injury. |
| [28] |
Wang J, Zheng X, Wang X, He Y, Xiao X, et al. 2025. Development of a gelatin methacryloyl double-layer membrane incorporated with nano-hydroxyapatite for guided bone regeneration. |
| [29] |
Altunbek M, Gezek M, Buck P, Camci-Unal G. 2024. Development of human-derived photocrosslinkable gelatin hydrogels for tissue engineering. |
| [30] |
Lotfi R, Dolatyar B, Zandi N, Tamjid E, Pourjavadi A, et al. 2025. Electrically conductive and photocurable MXene-modulated hydrogel conduits for peripheral nerve regeneration: in vitro and in vivo studies. |
| [31] |
Mohseni-Motlagh SF, Dolatabadi R, Baniassadi M, Baghani M. 2023. Application of the quality by design concept (QbD) in the development of hydrogel-based drug delivery systems. |
| [32] |
Karimi M, Abrishami M, Farzadnia M, Kamali H, Malaekeh-Nikouei B. 2024. In-situ forming biodegradable implants for sustained Fluocinolone acetonide release to the posterior eye: in-vitro and in-vivo investigations in rabbits. |
| [33] |
Zu H, Zhang K, Zhang H, Qian X. 2023. An inverse method to determine mechanical parameters of porcine vitreous bodies based on the indentation test. |
| [34] |
Ghosh S, Ghosh S, Sharma H, Bhaskar R, Han SS, et al. 2024. Harnessing the power of biological macromolecules in hydrogels for controlled drug release in the central nervous system: a review. |
| [35] |
Mamidi N, Franco De Silva F, Orash Mahmoudsalehi A. 2025. Advanced disease therapeutics using engineered living drug delivery systems. |
| [36] |
Holekamp NM, Yaqub M, Ranade SV, Cantrell RA, Singh S, et al. 2024. Systematic literature reviews comparing the long-term safety outcomes for the port delivery system with ranibizumab (PDS) versus other ocular implants. |
| [37] |
Mulkutkar M, Damani M, Sawarkar S. 2024. Polymeric microneedles for the eye: an overview of advances and ocular applications for minimally invasive drug delivery. |
| [38] |
Li Y, Rodrigues J, Tomás H. 2012. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. |
| [39] |
Vigata M, Meinert C, Pahoff S, Bock N, Hutmacher DW. 2020. Gelatin methacryloyl hydrogels control the localized delivery of albumin-bound paclitaxel. |
| [40] |
Schuurman W, Levett PA, Pot MW, van Weeren PR, Dhert WJA, et al. 2013. Gelatin-methacrylamide hydrogels as potential biomaterials for fabrication of tissue-engineered cartilage constructs. |
| [41] |
Shen F, Ge W, Ling H, Yang Y, Chen R, et al. 2024. Hemicellulose-based nanoaggregate-incorporated biocompatible hydrogels with enhanced mechanical properties and sustained controlled curcumin release behaviors. |
| [42] |
Wang SY, Tohti M, Zhang JQ, Li J, Li DQ. 2023. Acylhydrazone-derived whole pectin-based hydrogel as an injectable drug delivery system. |
| [43] |
Fernandes-Cunha GM, Fialho SL, da Silva GR, Silva-Cunha A, Zhao M, et al. 2017. Ocular safety of intravitreal clindamycin hydrochloride released by PLGA implants. |
| [44] |
Zolnik BS, Burgess DJ. 2007. Effect of acidic pH on PLGA microsphere degradation and release. |
| [45] |
Kim MS, Ahn HH, Shin YN, Cho MH, Khang G, et al. 2007. An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa-based scaffolds. |
| [46] |
Li DQ, Tohti M, Fu YS, Zhang Y, Xiong ZW, et al. 2024. Aldehyde group pendant-grafted pectin-based injectable hydrogel. |